Uncategorized

GC Genome Corporation, a leading diagnostics company, announced that the company will present data showcasing the deep learning algorithm that detects and classifies multi-cancer using methylation information and genomic data at the American Association for Cancer Research Annual Meeting 2023 in Orlando, Florida.

OSE Immunotherapeutics SA announces three presentations at the American Association for Cancer Research Annual Meeting in Orlando, April 14-19, 2023.

Glucose monitoring is a key link in diabetes management. Currently, there are two main methods for self-monitoring of glucose in patients with diabetes, one is the traditional blood glucose Monitoring, and the other is continuous glucose monitoring.

Sensorion a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, is pleased to announce its participation in two investor conferences in April 2023.

Data of InnoCare’s robust oncology pipelines were presented at the 2023 American Association for Cancer Research Annual Meeting.

BerGenBio ASA announced that it presented data linking AXL activation to STK11 loss of function in Non-Small Cell Lung Cancer in an abstract titled, AXL as a Therapeutic Target in STK11 mutant NSCLC, at the American Association for Cancer Research Annual Meeting 2023.

Marlena Fejzo, una genetista que sufrió náuseas y vómitos intensos durante el embarazo, hizo de la búsqueda de la causa de su enfermedad la hiperémesis gravídica su misión de vida.

The three former board members want the board to “heed the will of shareholders,” reopen nominations and bring forth other proposals — including the option to oust one or more current board directors.

Analysts from Needham and Stifel had opposite takes on how McDonald’s departure will affect the company, which has struggled in recent years to bring new products to market. 

The mammography AI company last month said it would lay off 28% of its staff to save money.